LGND · Ligand Pharmaceuticals Inc · Documents
$322.75
+5.42 (+1.71%)
At close · Oct 30
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$6.43B
Shares
20.00M
Volume · Oct 30
344.37K
Avg daily vol (3M)
241.18K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-07-10 | 2024-07-08 | |
| 8-K | — | 2024-07-08 | — | |
| 8-K | — | 2024-06-27 | — | |
| 8-K | — | 2024-06-18 | — | |
| 8-K | — | 2024-06-17 | 2024-06-14 | |
| DEFA14A | — | 2024-06-03 | — | |
| 8-K | — | 2024-05-30 | 2024-05-29 | |
| DEFA14A | — | 2024-05-09 | — | |
| 10-Q | — | 2024-05-08 | 2024-03-31 | |
| 8-K | — | 2024-05-07 | — | |
| 8-K | — | 2024-05-07 | 2024-05-06 | |
| DEF 14A | — | 2024-04-25 | 2023-12-31 | |
| ARS | — | 2024-04-25 | 2023-12-31 | |
| DEFA14A | — | 2024-04-25 | — | |
| 8-K | — | 2024-04-19 | 2024-04-17 | |
| 10-K | — | 2024-02-29 | 2023-12-31 | |
| 8-K | — | 2024-02-27 | — | |
| 8-K | — | 2024-01-08 | 2024-01-05 | |
| 8-K | — | 2023-12-01 | 2023-11-29 | |
| 8-K/A | — | 2023-11-13 | 2023-11-09 | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-11-08 | — | |
| 8-K | — | 2023-10-18 | 2023-10-12 | |
| 8-K | — | 2023-10-18 | — | |
| 8-K | — | 2023-09-27 | 2023-09-22 | |
| 8-K | — | 2023-09-18 | — | |
| 10-Q | — | 2023-08-09 | 2023-06-30 | |
| 8-K | — | 2023-08-08 | — | |
| 8-K | — | 2023-06-09 | — | |
| 10-Q | — | 2023-05-08 | 2023-03-31 | |
| 8-K | — | 2023-05-04 | — | |
| DEFA14A | — | 2023-04-20 | — | |
| DEF 14A | — | 2023-04-20 | — | |
| ARS | — | 2023-04-20 | 2022-12-31 | |
| 8-K | — | 2023-03-13 | — | |
| 10-K | — | 2023-02-28 | 2022-12-31 | |
| 8-K | — | 2023-02-22 | — | |
| 8-K | — | 2022-12-14 | 2022-12-13 | |
| 8-K | — | 2022-12-05 | — | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| 8-K | — | 2022-11-07 | — | |
| 8-K | — | 2022-11-04 | 2022-11-01 | |
| 8-K | — | 2022-10-03 | — | |
| 8-K | — | 2022-09-30 | — | |
| S-3ASR | — | 2022-09-30 | — | |
| 10-Q | — | 2022-08-09 | 2022-06-30 | |
| 8-K | — | 2022-08-08 | — | |
| 8-K | — | 2022-08-02 | 2022-07-29 | |
| 8-K | — | 2022-06-29 | — | |
| 8-K | — | 2022-06-21 | — |
Showing 51–100 of 163 filings
Key facts
CIK
886163
CUSIP
53220K504
13F (30d)
134 filings
125 filers
Visit website
Investor relations